CI
RGEN icon

Cordant Inc’s Repligen RGEN Stock Holding History

Cordant Inc’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6
Closed -$1K – 993
2022
Q1 		$1K Buy
+6
New +$1.14K ﹤0.01% 1074

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cordant Inc's RGEN Position: Q2 2022 in Review

Cordant Inc sold out of Repligen (RGEN) in Q2 2022, closing a stake of 6 shares — an estimated $1K sold.

Cordant Inc first reported a position in RGEN in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 404 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.

  • Cordant Inc reported no remaining Repligen position as of Q2 2022 after selling out during the quarter.
  • Cordant Inc sold 6 Repligen shares in Q2 2022, an estimated $1K.
  • Cordant Inc first reported a position in Repligen in Q1 2022 and held it in 1 quarter.
  • Cordant Inc's Repligen position peaked at $1K in Q1 2022.
  • 404 funds tracked by Wall St. Rank held Repligen as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.